On September 25, 2017, the US Food and Drug Administration (FDA) published final guidance—entitled Classification of Products as Drugs and Devices & Additional Product Classification Issues ...
On November 26th, the Centers for Medicare and Medicaid Services (CMS) released a Medicare Advantage (MA) and Part D drug pricing proposed rule for 2020 (Drug Pricing Proposed Rule) that includes ...
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new ...
A study published in Rheumatology & Autoimmunity challenges the assumption that achieving clinical remission in rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results